Literature DB >> 18948157

Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).

Petra Walcher1, Xianlan Cui, Jane A Arrow, Susie Scobie, Frank C Molinia, Phil E Cowan, Werner Lubitz, Janine A Duckworth.   

Abstract

The introduced brushtail possum is a serious pest in New Zealand and there is much interest in the development of an immunocontraceptive vaccine for population control. Immunisation of female possums against recombinant possum zona pellucida protein-2 (ZP2) is known to reduce embryo production by 72-75% but successful development of fertility control will depend on a delivery system that is effective for field use. Bacterial ghost vaccine technology is a promising system to formulate a non-living vaccine for bait or aerosol delivery. The N-terminal (amino acid residues 41-316, ZP2N) and C-terminal (amino acid residues 308-636, ZP2C) regions of possum ZP2 were fused to maltose-binding protein and expressed in the periplasmic space of Escherichia coli NM522 bacterial ghosts. Female possums (n=20 per treatment group) were immunised with 20mg of either plain ghosts, ZP2N ghosts, or ZP2C ghosts in phosphate-buffered saline applied to the nostrils and eyes (nasal/conjunctival mucosa) at weeks 0, 2 and 4. Effects of immunisation on fertility were assessed following superovulation and artificial insemination. Both constructs evoked humoral (antibody) and cell-mediated immune responses in possums and significantly fewer eggs were fertilised in females immunised against ZP2C ghosts. Results in this study indicate that bacterial ghosts containing possum ZP antigens can reduce possum fertility when delivered by mucosal immunisation and offer a promising delivery system for fertility control of wild possum populations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18948157     DOI: 10.1016/j.vaccine.2008.09.088

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Generation of Salmonella ghost cells expressing fimbrial antigens of enterotoxigenic Escherichia coli and evaluation of their antigenicity in a murine model.

Authors:  Chan Song Kim; Jin Hur; Seong Kug Eo; Sang-Youel Park; John Hwa Lee
Journal:  Can J Vet Res       Date:  2016-01       Impact factor: 1.310

Review 2.  Harnessing the potential of bacterial ghost for the effective delivery of drugs and biotherapeutics.

Authors:  Aditya Ganeshpurkar; Ankit Ganeshpurkar; Vikas Pandey; Abhishek Agnihotri; Divya Bansal; Nazneen Dubey
Journal:  Int J Pharm Investig       Date:  2014-01

Review 3.  Bacterial ghosts as adjuvants: mechanisms and potential.

Authors:  Irshad A Hajam; Pervaiz A Dar; Gayeon Won; John Hwa Lee
Journal:  Vet Res       Date:  2017-06-24       Impact factor: 3.683

4.  Subcutaneous Immunization of Dogs With Bordetella bronchiseptica Bacterial Ghost Vaccine.

Authors:  Abbas Muhammad; Johannes Kassmannhuber; Mascha Raucher; Alaric A Falcon; David W Wheeler; Alan A Zhang; Petra Lubitz; Werner Lubitz
Journal:  Front Immunol       Date:  2019-06-25       Impact factor: 7.561

5.  Efficient Robust Yield Method for Preparing Bacterial Ghosts by Escherichia coli Phage ID52 Lysis Protein E.

Authors:  Yi Ma; Wenjun Zhu; Guanshu Zhu; Yue Xu; Shuyu Li; Rui Chen; Lidan Chen; Jufang Wang
Journal:  Bioengineering (Basel)       Date:  2022-07-07

6.  Formulation and delivery of vaccines: Ongoing challenges for animal management.

Authors:  Sameer Sharma; Lyn A Hinds
Journal:  J Pharm Bioallied Sci       Date:  2012-10

7.  Delivery of a Chlamydial Adhesin N-PmpC Subunit Vaccine to the Ocular Mucosa Using Particulate Carriers.

Authors:  Aleksandra Inic-Kanada; Marijana Stojanovic; Simone Schlacher; Elisabeth Stein; Sandra Belij-Rammerstorfer; Emilija Marinkovic; Ivana Lukic; Jacqueline Montanaro; Nadine Schuerer; Nora Bintner; Vesna Kovacevic-Jovanovic; Ognjen Krnjaja; Ulrike Beate Mayr; Werner Lubitz; Talin Barisani-Asenbauer
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240

Review 8.  Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems.

Authors:  Mounir M Salem-Bekhit; Abdullah M E Youssof; Fars K Alanazi; Fadilah Sfouq Aleanizy; Alsuwyeh Abdulaziz; Ehab I Taha; Amro Abd Al Fattah Amara
Journal:  Pharmaceutics       Date:  2021-11-23       Impact factor: 6.321

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.